Timing of Antidiabetic Medication Initiation and Risk of Cardiovascular Events and Mortality

Jama Network Open

by Hwa Yeon Ko, Ju-Young Shin, Kyungyeon Jung, Sungho Bea, Bin Hong, Yunha Noh, Jae Hyun Bae, Soo Heon Kwak, Young Min Cho, Ga-young Lim, Jiin Ahn, Seungho Ryu, Ju Hwan Kim, Yoosoo Chang
June 22, 2026

Jama Ophthalmology

Brolucizumab in the Treatment of Proliferative Diabetic Retinopathy: The CONDOR Randomized Clinical Trial

by Sebastian Wolf, Youxin Chen, Xiaorong Li, Masahiko Shimura, Taiji Sakamoto, Charles C. Wykoff, Andres Emanuelli, Hani Salehi-Had, Kang Yan, Lidija Kovacic, Yongsoo Kim
June 1, 2026

Conexiant

AI Tool May Cut Macular Edema Referrals

An artificial intelligence–based optical coherence tomography pathway met noninferiority criteria for false-positive diabetic macular edema referrals and was associated with fewer referral decisions in a randomized clinical trial.

by Andrea Surnit
June 18, 2026
4 min

Frontiers In Neurology

Timing of Antidiabetic Medication Initiation and Risk of Cardiovascular Events and Mortality

Original Source(s)

Timing of Antidiabetic Medication Initiation and Risk of Cardiovascular Events and Mortality

Related Content

Brolucizumab in the Treatment of Proliferative Diabetic Retinopathy: The CONDOR Randomized Clinical Trial

AI Tool May Cut Macular Edema Referrals

Impact of Parakinesia brachialis oscitans on limb functional recovery after stroke: a cohort study